BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8988509)

  • 21. Effects of zinc supplementation on the survival of patients who received concomitant chemotherapy and radiotherapy for advanced nasopharyngeal carcinoma: follow-up of a double-blind randomized study with subgroup analysis.
    Lin YS; Lin LC; Lin SW
    Laryngoscope; 2009 Jul; 119(7):1348-52. PubMed ID: 19402154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of stage IV(A-B) nasopharyngeal carcinoma by induction-concurrent chemoradiotherapy and accelerated fractionation.
    Lee AW; Yau TK; Wong DH; Chan EW; Yeung RM; Ng WT; Tong M; Soong IS; Sze WM
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1331-8. PubMed ID: 16169677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment outcomes of patients with AJCC stage IVC nasopharyngeal carcinoma: benefits of primary radiotherapy.
    Yeh SA; Tang Y; Lui CC; Huang EY
    Jpn J Clin Oncol; 2006 Mar; 36(3):132-6. PubMed ID: 16520357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neoadjuvant chemotherapy followed by concurrent chemo-radiation therapy in locally advanced nasopharyngeal carcinoma.
    Al-Amro A; Al-Rajhi N; Khafaga Y; Memon M; Al-Hebshi A; El-Enbabi A; El-Husseiny G; Radawi A; Belal A; Allam A; El-Sebaie M
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):508-13. PubMed ID: 15890594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hypertrophic osteoarthropathy in a patient with nasopharyngeal carcinoma].
    Vera Sempere FJ; Botella Rodríguez MS; Aparisi Mocholi F; Morera Pérez C
    Acta Otorrinolaringol Esp; 1995; 46(1):67-70. PubMed ID: 7734170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neoadjuvant chemotherapy followed by concurrent chemoradiation for locoregionally advanced nasopharyngeal carcinoma: interim results from 2 prospective phase 2 clinical trials.
    Kong L; Hu C; Niu X; Zhang Y; Guo Y; Tham IW; Lu JJ
    Cancer; 2013 Dec; 119(23):4111-8. PubMed ID: 24037893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparative study of locoregionally advanced nasopharyngeal carcinoma treated with intensity modulated irradiation and platinum-based chemotherapy.
    Xu JH; Guo WJ; Bian XH; Wu JF; Jiang XS; Guo YS; He X
    Cancer Radiother; 2013; 17(4):297-303. PubMed ID: 23849438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concomitant chemoradiotherapy for advanced head and neck cancer.
    Lin JC; Jan JS; Hsu CY
    Jpn J Clin Oncol; 1994 Apr; 24(2):94-100. PubMed ID: 8158863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proposed lymph node staging system using the International Consensus Guidelines for lymph node levels is predictive for nasopharyngeal carcinoma patients from endemic areas treated with intensity modulated radiation therapy.
    Li WF; Sun Y; Mao YP; Chen L; Chen YY; Chen M; Liu LZ; Lin AH; Li L; Ma J
    Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):249-56. PubMed ID: 23200171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group.
    Chua DT; Sham JS; Choy D; Lorvidhaya V; Sumitsawan Y; Thongprasert S; Vootiprux V; Cheirsilpa A; Azhar T; Reksodiputro AH
    Cancer; 1998 Dec; 83(11):2270-83. PubMed ID: 9840526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concurrent chemoradiotherapy in locoregionally recurrent nasopharyngeal carcinoma.
    Poon D; Yap SP; Wong ZW; Cheung YB; Leong SS; Wee J; Tan T; Fong KW; Chua ET; Tan EH
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1312-8. PubMed ID: 15275714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Combined induction chemotherapy and radiotherapy in case of undifferentiated carcinoma of nasopharynx tumours (UCNT)].
    Righini ChA; Soriano E; Morel N; Hitter A; Bolla M; Reyt E
    Rev Laryngol Otol Rhinol (Bord); 2006; 127(4):223-8. PubMed ID: 17315786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Metastatic nasopharyngeal carcinoma: clinical study and therapeutic results of 95 cases].
    Khanfir A; Frikha M; Ghorbel A; Karray H; Drira MM; Daoud J
    Cancer Radiother; 2006 Dec; 10(8):545-9. PubMed ID: 16807035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pilot study of concurrent cisplatin, 5-fluorouracil, and external beam radiotherapy prior to radical surgery +/- intraoperative electron beam radiotherapy in locally advanced cervical cancer.
    Jurado M; Martínez-Monge R; García-Foncillas J; Azinovic I; Aristu J; López-García G; Brugarolas A
    Gynecol Oncol; 1999 Jul; 74(1):30-7. PubMed ID: 10385548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A comparison of two modalities of complex chemoradiotherapy for locally advanced nasopharyngeal carcinoma].
    Alieva SB; Tkachëv SI; Matiakin EG; Kondrat'eva AP; Zimina NA; Sakharovskaia VG; Iachmeneva NF; Romanov IS
    Vopr Onkol; 2004; 50(6):701-5. PubMed ID: 15755067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes following chemoradiotherapy for N3 head and neck squamous cell carcinoma without a planned neck dissection.
    Karakaya E; Yetmen O; Oksuz DC; Dyker KE; Coyle C; Sen M; Prestwich RJ
    Oral Oncol; 2013 Jan; 49(1):55-9. PubMed ID: 22858313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neo-adjuvant Docetaxel and Cisplatin followed by concurrent Cisplatin with radiation therapy in treatment of locally advanced nasopharyngeal carcinoma.
    Hassan E; Galal K; Esmat E
    Gulf J Oncolog; 2008 Jan; (3):46-53. PubMed ID: 20084797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Staging bone scintigraphy in nasopharyngeal carcinoma.
    Leung SF; Stewart IE; Tsao SY; Metreweli C
    Clin Radiol; 1991 May; 43(5):314-5. PubMed ID: 2036755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concurrent chemoradiotherapy with adjuvant chemotherapy for high-risk nasopharyngeal carcinoma.
    Lee CC; Chu ST; Chou P
    Auris Nasus Larynx; 2009 Dec; 36(6):688-94. PubMed ID: 19410399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outpatient weekly neoadjuvant chemotherapy followed by radiotherapy for advanced nasopharyngeal carcinoma: high complete response and low toxicity rates.
    Lin JC; Jan JS; Hsu CY; Jiang RS; Wang WY
    Br J Cancer; 2003 Jan; 88(2):187-94. PubMed ID: 12610501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.